$AIFF
FIREFLY NEUROSCIENCE, INC.

2021 Q4 Form 10-Q Financial Statement

#000143774921024909 Filed on November 02, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $2.582M $4.300M $3.100M
YoY Change -16.71% 9.62% 47.62%
Cost Of Revenue $1.921M $3.321M $2.170M
YoY Change -11.48% 0.38% 23.3%
Gross Profit $661.2K $978.9K $930.0K
YoY Change -28.91% 59.34% 173.53%
Gross Profit Margin 25.61% 22.76% 30.0%
Selling, General & Admin $2.965M $1.001M $570.0K
YoY Change 420.11% 191.99% 18.75%
% of Gross Profit 448.39% 102.25% 61.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $125.5K $55.15K $3.180K
YoY Change 3845.91% 708.65% -68.2%
% of Gross Profit 18.98% 5.63% 0.34%
Operating Expenses $2.965M $1.001M $570.0K
YoY Change 420.11% 191.99% 18.75%
Operating Profit -$2.303M -$84.27K $360.0K
YoY Change -739.86% -139.21% -357.14%
Interest Expense -$37.33K $15.06K
YoY Change
% of Operating Profit
Other Income/Expense, Net $32.31K -$11.26K $0.00
YoY Change 5446.8%
Pretax Income -$2.421M -$95.53K $360.0K
YoY Change -772.43% -144.49% -357.14%
Income Tax -$1.071M $0.00
% Of Pretax Income
Net Earnings -$1.350M -$95.53K $360.0K
YoY Change -474.97% -144.49% -357.14%
Net Earnings / Revenue -52.28% -2.22% 11.61%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$93.60K -$0.01 $28.19K
COMMON SHARES
Basic Shares Outstanding 13.51M 12.60M
Diluted Shares Outstanding 12.60M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.931M $3.683M $1.860M
YoY Change 165.12% 150.63% 78.85%
Cash & Equivalents $4.931M $3.683M $1.858M
Short-Term Investments
Other Short-Term Assets $6.826K $5.556K $4.790K
YoY Change 42.51% -85.6% 53.53%
Inventory
Prepaid Expenses $283.6K $142.8K
Receivables $1.665M $2.875M $1.442M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.873M $6.846M $3.443M
YoY Change 99.62% 120.27% 55.92%
LONG-TERM ASSETS
Property, Plant & Equipment $105.3K $94.97K $62.17K
YoY Change 69.31% 54.41% 542.14%
Goodwill $7.585M $785.0K $0.00
YoY Change
Intangibles $8.049M $1.402M $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $77.10K $5.707K $6.281K
YoY Change 1127.51% -9.14% 0.0%
Total Long-Term Assets $16.49M $2.573M $330.5K
YoY Change 4888.65% 1001.09% 99.45%
TOTAL ASSETS
Total Short-Term Assets $6.873M $6.846M $3.443M
Total Long-Term Assets $16.49M $2.573M $330.5K
Total Assets $23.36M $9.420M $3.774M
YoY Change 519.09% 181.87% 58.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $650.5K $926.6K $103.6K
YoY Change 527.62% 73.76% -52.07%
Accrued Expenses $920.3K $676.1K $480.0K
YoY Change 91.72% -1.19% 26.32%
Deferred Revenue $186.8K $78.05K $946.9K
YoY Change -80.27% -76.47% 103.97%
Short-Term Debt $0.00 $402.3K $0.00
YoY Change
Long-Term Debt Due $0.00 $797.3K $93.01K
YoY Change -100.0% 2045.59%
Total Short-Term Liabilities $1.982M $3.117M $1.803M
YoY Change 9.9% 82.73% 54.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $400.9K $357.0K
YoY Change -100.0% -2.9%
Other Long-Term Liabilities $2.265M $260.1K $0.00
YoY Change -100.0%
Total Long-Term Liabilities $2.265M $661.0K $357.0K
YoY Change 534.47% 60.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.982M $3.117M $1.803M
Total Long-Term Liabilities $2.265M $661.0K $357.0K
Total Liabilities $5.921M $3.778M $2.160M
YoY Change 174.1% 78.32% 78.29%
SHAREHOLDERS EQUITY
Retained Earnings -$13.44M -$12.09M -$12.31M
YoY Change 9.19% -4.56% -3.25%
Common Stock $18.88K $151.5K $129.0K
YoY Change -85.37% 17.88% 0.39%
Preferred Stock
YoY Change
Treasury Stock (at cost) $930.2K $930.2K $930.2K
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares $1.643M $1.643M $1.643M
Shareholders Equity $17.44M $5.642M $1.613M
YoY Change
Total Liabilities & Shareholders Equity $23.36M $9.420M $3.774M
YoY Change 519.09% 181.87% 58.96%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$1.350M -$95.53K $360.0K
YoY Change -474.97% -144.49% -357.14%
Depreciation, Depletion And Amortization $125.5K $55.15K $3.180K
YoY Change 3845.91% 708.65% -68.2%
Cash From Operating Activities -$309.2K -$309.7K $381.4K
YoY Change -181.07% -902.9% -735.72%
INVESTING ACTIVITIES
Capital Expenditures -$13.74K -$33.56K -$1.360K
YoY Change 910.29% -42.77%
Acquisitions
YoY Change
Other Investing Activities -$7.279M $0.00
YoY Change
Cash From Investing Activities -$7.292M -$33.55K -$1.360K
YoY Change 536097.79% -42.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.850M 2.493M 10.00K
YoY Change 88401.8% 454.02%
NET CHANGE
Cash From Operating Activities -309.2K -309.7K 381.4K
Cash From Investing Activities -7.292M -33.55K -1.360K
Cash From Financing Activities 8.850M 2.493M 10.00K
Net Change In Cash 1.249M 2.150M 390.1K
YoY Change 220.12% 400.05% -750.12%
FREE CASH FLOW
Cash From Operating Activities -$309.2K -$309.7K $381.4K
Capital Expenditures -$13.74K -$33.56K -$1.360K
Free Cash Flow -$295.5K -$276.1K $382.8K
YoY Change -177.19% -384.04% -737.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13510690
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
87912 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
312320 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
349300 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15153306
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12904376
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13510690
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11261760
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1642616
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1642616
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055 pure
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P61M
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P53M
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P53M
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P41M
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3682613 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1858160 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2874656 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1442231 USD
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
283567 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
142770 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
5556 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
6846392 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
3443161 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1402088 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 USD
CY2021Q3 us-gaap Goodwill
Goodwill
785000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
0 USD
CY2021Q3 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
0 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
210688 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
285667 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
51405 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
94965 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62166 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5707 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6281 USD
CY2021Q3 us-gaap Assets
Assets
9419819 USD
CY2020Q4 us-gaap Assets
Assets
3773701 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
926643 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
103646 USD
CY2021Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
402306 USD
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
797295 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
93009 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
555483 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
375168 USD
CY2021Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
236438 USD
CY2020Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
181626 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
82158 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
54274 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
78045 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
946884 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35805 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45595 USD
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2666 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3125 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3116839 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1803327 USD
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
400856 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
356991 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
260141 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2021Q3 us-gaap Liabilities
Liabilities
3777836 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2160318 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
151532 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
129043 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18507731 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14720065 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12087069 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12305514 USD
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
930211 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
930211 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
5641983 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1613383 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9419819 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3773701 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4299925 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3922746 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
3321050 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
3308419 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
978875 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
614327 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1000880 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
342778 USD
CY2021Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
23017 USD
CY2020Q3 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
56643 USD
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
39245 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-84267 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
214906 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11260 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-203 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-95527 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
214703 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-95527 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
214703 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-95527 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
214703 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12596126
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11211760
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1049761 USD
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
176660 USD
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
179560 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
192530 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
238583 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
52850 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20138 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12596126
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11837427
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12451467 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10803897 USD
us-gaap Cost Of Revenue
CostOfRevenue
9497014 USD
us-gaap Cost Of Revenue
CostOfRevenue
9521726 USD
us-gaap Gross Profit
GrossProfit
2954453 USD
us-gaap Gross Profit
GrossProfit
1282171 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2346680 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
894 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
218445 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
53744 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
218445 USD
us-gaap Net Income Loss
NetIncomeLoss
53744 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
218445 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53744 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11957878
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11211760
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12584914
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11810392
us-gaap Net Income Loss
NetIncomeLoss
218445 USD
us-gaap Net Income Loss
NetIncomeLoss
53744 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
111123 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6821 USD
us-gaap Share Based Compensation
ShareBasedCompensation
220455 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7171 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
820954 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
931517 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
140015 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-461592 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-210688 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
89404 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-16663 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
508408 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
317048 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-868839 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-132574 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
63404 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
334325 USD
us-gaap Increase Decrease In Reserve For Commissions Expense And Taxes
IncreaseDecreaseInReserveForCommissionsExpenseAndTaxes
-54812 USD
us-gaap Increase Decrease In Reserve For Commissions Expense And Taxes
IncreaseDecreaseInReserveForCommissionsExpenseAndTaxes
-11363 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-425810 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
56010 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58640 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38569 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2233884 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2289894 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58640 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
502306 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
100000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
-0 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1000000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
450000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
251849 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
-0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3294554 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
95146 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4540157 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
450000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1824453 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
429929 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1858160 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1039442 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3682613 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1469371 USD
us-gaap Interest Paid Net
InterestPaidNet
32197 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Stock Issued1
StockIssued1
200000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1613383 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
270815 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27711 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
495999 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3550 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2411458 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
43157 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
111862 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
198555 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
79995 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2845027 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-95527 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
80882 USD
CY2021Q3 iaic Adjustments To Additional Paid In Capital Stock And Warrant Issued
AdjustmentsToAdditionalPaidInCapitalStockAndWarrantIssued
2800000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11601 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
5641983 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1162376 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-126339 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
450 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1036487 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-34620 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
356 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1002223 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
214703 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6365 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1223291 USD
CY2020Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2020Q2 iaic Contract With Customer Asset Contract Assets Added
ContractWithCustomerAssetContractAssetsAdded
13918 USD
CY2020Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
13918 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="text-decoration: underline; ">Use of Estimates and Assumptions</span></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2020Q3 iaic Contract With Customer Asset Contract Assets Added
ContractWithCustomerAssetContractAssetsAdded
75486 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
80882 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6365 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
220455 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7171 USD
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2700000 USD
CY2021Q2 iaic Contract With Customer Asset Contract Assets Added
ContractWithCustomerAssetContractAssetsAdded
134657 USD
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
477268 USD
CY2021Q3 iaic Contract With Customer Asset Contract Assets Added
ContractWithCustomerAssetContractAssetsAdded
45895 USD
CY2021Q3 iaic Contract With Customer Asset Reduction
ContractWithCustomerAssetReduction
523163 USD
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4299925 USD
CY2021Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
pure
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3922746 USD
CY2020Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12451467 USD
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10803897 USD
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
pure
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
210688 USD
CY2021Q1 iaic Contract With Customer Asset Contract Assets Added
ContractWithCustomerAssetContractAssetsAdded
131923 USD
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
342611 USD
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
89404 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
946884 USD
CY2021Q1 iaic Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
93934 USD
CY2021Q1 iaic Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
585322 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
455496 USD
CY2021Q2 iaic Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
4815 USD
CY2021Q2 iaic Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
354427 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
105884 USD
CY2021Q3 iaic Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
79640 USD
CY2021Q3 iaic Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
107479 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
78045 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
464223 USD
CY2020Q1 iaic Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
19136 USD
CY2020Q1 iaic Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
212568 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
270791 USD
CY2020Q2 iaic Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
9906 USD
CY2020Q2 iaic Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
216353 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
64344 USD
CY2020Q3 iaic Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
480024 USD
CY2020Q3 iaic Contract With Customer Liability Revenue Recognized During Period
ContractWithCustomerLiabilityRevenueRecognizedDuringPeriod
212719 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
331649 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
946884 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
464223 USD
iaic Number Of Subcontracts With Significant Financing Component
NumberOfSubcontractsWithSignificantFinancingComponent
1 pure
iaic Subcontract Payments Receivable Under Regular Terms Percent
SubcontractPaymentsReceivableUnderRegularTermsPercent
0.90 pure
iaic Subcontract Payments Receivable Deferred Until Specific Deliverable Is Met Percent
SubcontractPaymentsReceivableDeferredUntilSpecificDeliverableIsMetPercent
0.10 pure
iaic Subcontract Payments Receivable Interest Rate
SubcontractPaymentsReceivableInterestRate
0.045 pure
CY2020Q4 iaic Deferred Costs Of Revenue
DeferredCostsOfRevenue
89068 USD
CY2021Q1 iaic Deferred Costs Of Revenue Added
DeferredCostsOfRevenueAdded
17406 USD
CY2021Q1 iaic Deferred Costs Of Revenue Expense
DeferredCostsOfRevenueExpense
75223 USD
CY2021Q1 iaic Deferred Costs Of Revenue
DeferredCostsOfRevenue
31251 USD
CY2021Q2 iaic Deferred Costs Of Revenue Added
DeferredCostsOfRevenueAdded
11188 USD
CY2021Q2 iaic Deferred Costs Of Revenue Expense
DeferredCostsOfRevenueExpense
16681 USD
CY2021Q2 iaic Deferred Costs Of Revenue
DeferredCostsOfRevenue
25758 USD
CY2021Q3 iaic Deferred Costs Of Revenue Added
DeferredCostsOfRevenueAdded
194686 USD
CY2021Q3 iaic Deferred Costs Of Revenue Expense
DeferredCostsOfRevenueExpense
33118 USD
CY2021Q3 iaic Deferred Costs Of Revenue
DeferredCostsOfRevenue
187326 USD
CY2019Q4 iaic Deferred Costs Of Revenue
DeferredCostsOfRevenue
453607 USD
CY2020Q1 iaic Deferred Costs Of Revenue Added
DeferredCostsOfRevenueAdded
181 USD
CY2020Q1 iaic Deferred Costs Of Revenue Expense
DeferredCostsOfRevenueExpense
207437 USD
CY2020Q1 iaic Deferred Costs Of Revenue
DeferredCostsOfRevenue
246351 USD
CY2020Q2 iaic Deferred Costs Of Revenue Added
DeferredCostsOfRevenueAdded
2472 USD
CY2020Q2 iaic Deferred Costs Of Revenue Expense
DeferredCostsOfRevenueExpense
192548 USD
CY2020Q2 iaic Deferred Costs Of Revenue
DeferredCostsOfRevenue
56275 USD
CY2020Q3 iaic Deferred Costs Of Revenue Added
DeferredCostsOfRevenueAdded
0 USD
CY2020Q3 iaic Deferred Costs Of Revenue Expense
DeferredCostsOfRevenueExpense
54477 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
295946 USD
CY2020Q3 iaic Deferred Costs Of Revenue
DeferredCostsOfRevenue
1798 USD
CY2021Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P66M
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
900 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
285667 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
51405 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35805 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45595 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
260141 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
45595 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
0 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
69334 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
71210 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
54699 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
75111 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
51327 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
321681 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
25735 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
295946 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055 pure
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
15985 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
26122 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
68229 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
78365 USD
CY2021Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
2874656 USD
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1442231 USD
CY2021Q3 us-gaap Escrow Deposit
EscrowDeposit
272000 USD
CY2021Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1490000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
87912 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1402088 USD
CY2021Q3 us-gaap Goodwill
Goodwill
785000 USD
CY2021Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
2187088 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
44061 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87912 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
44061 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
176244 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
176244 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
146259 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
136248 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
136248 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
306784 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1122088 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0084 pure
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0026 pure
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.468 pure
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.696 pure
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1395000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.31
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
145000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.62
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
25000
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.14
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1515000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.53
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
127500
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.85
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
360000
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.22
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
20000
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.17
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1262500
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.86
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.80
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
65000
CY2021Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.18
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1227500
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.94
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2450068 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
930000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.44
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2326943 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1349000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.23
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
129000
CY2020Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.17
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1220000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.24
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.15
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
10000
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.19
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1220000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.24
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
210000
CY2020Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.66
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1430000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.30
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
487773 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1208500
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.24
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
482268 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
210000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
302500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
220000
CY2021Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
65000
CY2020Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
450000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
163847 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
80882 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6365 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
220455 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7171 USD
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
235000
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.36
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
145000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.22
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
-0
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
380000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.94
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
127500
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.19
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
25000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.01
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
482500
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.81
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.15
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
215000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.41
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
297500
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.13
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
23500
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.17
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
5000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.21
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
18500
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.15
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
10000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.08
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
15500
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.16
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
13000
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.09
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
210000
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.37
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1500
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.12
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
221500
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.36
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
791667 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0 USD
CY2021Q3 us-gaap Notes Payable
NotesPayable
1198151 USD
CY2020Q4 us-gaap Notes Payable
NotesPayable
450000 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
797295 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
93009 USD
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
400856 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
356991 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-95527 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12596126
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-95527 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12596126
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
214703 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11211760
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
625667
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
214703 USD
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11837427
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
218445 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11957878
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
627036
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
218445 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12584914
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
53745 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11211760
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
598632
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
53745 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11810392
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0

Files In Submission

Name View Source Status
0001437749-21-024909-index-headers.html Edgar Link pending
0001437749-21-024909-index.html Edgar Link pending
0001437749-21-024909.txt Edgar Link pending
0001437749-21-024909-xbrl.zip Edgar Link pending
ex_297762.htm Edgar Link pending
ex_297763.htm Edgar Link pending
ex_297764.htm Edgar Link pending
ex_297765.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
iaic-20210930.xsd Edgar Link pending
iaic-20210930_cal.xml Edgar Link unprocessable
iaic-20210930_def.xml Edgar Link unprocessable
iaic-20210930_lab.xml Edgar Link unprocessable
iaic-20210930_pre.xml Edgar Link unprocessable
iaic20210930_10q.htm Edgar Link pending
iaic20210930_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending